• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021;27(8):2081-2089.
doi: 10.3201/eid2708.210667.
Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing

Sarah E Smith-Jeffcoat, Mitsuki Koh, Adam Hoffman, Paulina A Rebolledo, Marcos C Schechter, Halie K Miller, Sadia Sleweon, Rebecca Rossetti, Vyjayanti Kasinathan, Talya Shragai, Kevin O'Laughlin, Catherine C Espinosa, George M Khalil, AdeSubomi O Adeyemo, Anne Moorman, Brenda L Bauman, Kahaliah Joseph, Michelle O'Hegarty, Nazia Kamal, Hany Atallah, Brooks L Moore, Caitlin D Bohannon, Bettina Bankamp, Claire Hartloge, Michael D Bowen, Ashley Paulick, Amy S Gargis, Christopher Elkins, Rebekah J Stewart, Juliana da Silva, Caitlin Biedron, Jacqueline E Tate, Yun F Wang, Hannah L Kirking, CDC COVID-19; Response Team1

Abstract

We evaluated the performance of self-collected anterior nasal swab (ANS) and saliva samples compared with healthcare worker-collected nasopharyngeal swab specimens used to test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used the same PCR diagnostic panel to test all self-collected and healthcare worker-collected samples from participants at a public hospital in Atlanta, Georgia, USA. Among 1,076 participants, 51.9% were men, 57.1% were >50 years of age, 81.2% were Black (non-Hispanic), and 74.9% reported >1 chronic medical condition. In total, 8.0% tested positive for SARS-CoV-2. Compared with nasopharyngeal swab samples, ANS samples had a sensitivity of 59% and saliva samples a sensitivity of 68%. Among participants tested 3-7 days after symptom onset, ANS samples had a sensitivity of 80% and saliva samples a sensitivity of 85%. Sensitivity varied by specimen type and patient characteristics. These findings can help physicians interpret PCR results for SARS-CoV-2.

Keywords: 2019 novel coronavirus disease; COVID-19; Georgia; SARS-CoV-2; United States; anterior nasal; coronavirus disease; coronaviruses; respiratory infections; saliva; self-collected; sensitivity; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom